RNS Number : 7681C
Duke Capital Limited
31 March 2025
 

31 March 2025

Duke Capital Limited

 

("Duke Capital", "Duke" or the "Company")

 

Trading and Operational Update

 

Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, is pleased to provide guidance on its trading for the fourth quarter of the financial year ending 31 March 2025 ("Q4 FY25").

 

Trading Update

 

Based on current trading, Duke expects to achieve recurring cash revenue* of £6.5 million in Q4 FY25. This represents a 12% year-on-year increase on Q4 FY24 (£5.8 million) and equal to the prior quarter, Q3 FY25, which saw the Company deliver recurring cash revenue of £6.5 million.

 

Overview of quarterly revenue growth:

 

 

Recurring Cash Revenue*

Total Cash Revenue**

Q3 FY24

£6.3 million

£6.3 million

Q4 FY24

£5.8 million

£10.2 million

Q1 FY25

£6.3 million

£6.8 million

Q2 FY25

£6.4 million

£6.8 million

Q3 FY25

£6.5 million

£6.5 million

 

* Recurring cash revenue excludes exit premium receipts and cash gains from equity sales

** Total cash revenue is monthly cash distributions from Duke's partners plus exit premium receipts and cash gains from equity sales

 

 

Operational Update

 

In February, Duke completed a £1.9 million follow-on investment into BPVA (Ireland) Limited to facilitate the acquisition of Pinta Crew Limited, an Irish consultancy business specialising in helping Irish and international organisations optimise their people, processes and resources.

 

Neil Johnson, CEO of Duke Capital, said:

 

"Despite the UK's stickier inflationary pressures, we are pleased to report that we are on track to achieve a solid year-on-year increase in recurring cash revenues for Q4 FY25. This performance reflects the strength of our business model in navigating challenging market conditions, while our follow-on investment in BPVA underscores our commitment to supporting our portfolio. With a strong balance sheet, we are confident we can deliver long-term, sustainable value for shareholders."

 

***ENDS***

 

For further information, please visit https://dukecapital.com/ or contact:

 

Duke Capital Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 231 816

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Stephen Keys / Callum Davidson / Michael Johnson 

+44 (0) 207 220 0500

 




Canaccord Genuity Limited

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (Financial Communications)

Robin Tozer / Alice Cho / Olivia Hart

+ +44 (0) 20 3757 6882 dukecapital@secnewgate.co.uk

 

 

About Duke Capital

 

Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.

 

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.

 

Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. It's three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits.

 

Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKFBQABKDNNB